GNLX
Genelux Corporation Common Stock
NASDAQ: GNLX · HEALTHCARE · BIOTECHNOLOGY
$2.67
+6.80% today
Updated 2026-04-30
Market cap
$114.70M
P/E ratio
—
P/S ratio
14,337.86x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$2 – $9
Volume
0.2M
Genelux Corporation Common Stock (GNLX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |